阿维菌素的中国“智”造

doi:10.16288/j.yczz. 18-194

遗传 ›› 2018, Vol. 40 ›› Issue (10): 888-899.doi: 10.16288/j.yczz. 18-194

阿维菌素的中国“智”造

文莹¹(),张立新²()

^1. 中国农业大学生物学院,农业生物技术国家重点实验室,北京 100193
^2. 华东理工大学,生物反应器工程国家重点实验室,上海 200237

收稿日期:2018-07-10 修回日期:2018-09-13 出版日期:2018-10-20 发布日期:2018-10-26
作者简介:文莹,博士,教授,研究方向：链霉菌抗生素生物合成调控及代谢工程育种。E-mail: wen@cau.edu.cn
基金资助:
国家自然科学基金项目(31430002);国家自然科学基金项目(31320103911);国家自然科学基金项目(31500690);国家自然科学基金项目(31670052);国家自然科学基金项目(31600017);国家重点研发项目(2017YFD0201207);华东理工大学交叉团队项目(22221818014);山东省重点研发项目(ZR2017ZB0206);泰山学者计划项目资助

Avermectins, intelligently made in China

Ying Wen¹(),Lixin Zhang²()

^1. State Key Laboratory of Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing 100193, China
^2. State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China

Received:2018-07-10 Revised:2018-09-13 Online:2018-10-20 Published:2018-10-26
Supported by:
the National Natural Science Foundation of China(31430002);the National Natural Science Foundation of China(31320103911);the National Natural Science Foundation of China(31500690);the National Natural Science Foundation of China(31670052);the National Natural Science Foundation of China(31600017);the National Key Research And Development Program of China(2017YFD0201207);the Fundamental Research Funds for the Central Universities(22221818014);the Major Basic Program of the Natural science Foundation of Shandong Province(ZR2017ZB0206);the Shandong Taishan Scholar Program of China for L.Z.

摘要/Abstract

摘要：

阿维菌素(avermectins)是由微生物发酵生产的高效低毒生物杀虫剂,在粮食安全、农产品安全、畜牧业和医药健康等领域具有重大意义。其衍生物伊维菌素(ivermectins)可有效治疗河盲症,帮助超过2亿非洲人幸免于失明。我国的阿维菌素产业利用遗传学改造手段深入挖掘微生物的潜能,大幅度提高了底物利用率、目标产物得率和反应器产率,打破了美国默克公司的产品垄断,从无到有,从弱到强,直至独占全球市场。阿维菌素的生物“智”造不但成为实验室技术向产业成功转化的典范,为其他微生物天然产物药物的研发提供了可借鉴的策略和方法,而且得到广泛的国际认可。本文介绍了阿维菌素的发现、基础及应用研究的发展历程,尤其是中国“智”造的历史沿革,旨在为我国微生物药物的产业化发展提供参考和借鉴。

关键词: 阿维菌素, 伊维菌素, 遗传学改造, 产量提高

Abstract:

Avermectins, are pesticides of fermentation products with high efficacy and low toxicity and play important roles in food and agricultural product safety, animal and human health. Ivermectins, the derivatives of avermectins, are used to treat Onchocerciasis, also known as River Blindness. Thanks to these discoveries, more than 200 million Africans are lucky to be exempted from blindness. Great efforts have been made on better understanding of the microbial production system of avermectins through genetic engineering in China. Starting from scratch, Chinese avermectin industry has experienced a comprehensive technological innovation with significantly improved yield, titer and productivity of avermectins, and became the exclusive supplier for the global market. The success of avermectin industry innovation in China not only shed lights on the intelligent yield improvement of other microbial natural product drugs, but also gained wide international recognition. We provide here an overview of the discovery and development of basic and applied research of avermectins, especially historical evolution of avermectins made in China, which will benefit industrial development of microbial drugs in China.

Key words: avermectins, ivermectins, genetic engineering, yield improvement

文莹, 张立新. 阿维菌素的中国“智”造[J]. 遗传, 2018, 40(10): 888-899.

Ying Wen, Lixin Zhang. Avermectins, intelligently made in China[J]. Hereditas(Beijing), 2018, 40(10): 888-899.

参考文献

[1]	Chen JS, Liu M, Zhang LX . Avermectin, from winning the Nobel Prize to "innovation in China". Acta microbiol Sin, 2016,56(3):543-558.
[1]	陈金松, 刘梅, 张立新 . 从阿维菌素获得诺贝尔奖到中国创造. 微生物学报, 2016,56(3):543-558.
[2]	Burg RW, Miller BM, Baker EE, Birnbaum J, Currie SA, Hartman R, Kong YL, Monaghan RL, Olson G, Putter I, Tunac JB, Wallick H, Stapley EO, Oiwa R, Omura S . Avermectins, new family of potent anthelmintic agents: producing organism and fermentation. Antimicrob Agents Chemoth, 1979,15(3):361-367.
[3]	Miller TW, Chaiet L, Cole DJ, Cole LJ, Flor JE, Goegelman RT, Gullo VP, Joshua H, Kempf AJ, Krellwitz WR, Monaghan RL, Ormond RE, Wilson KE, Albers- Sch?nberg G, Putter I . Avermectins, new family of potent anthelmintic agents: isolation and chromatographic properties. Antimicrob Agents Chemoth, 1979,15(3):368-371.
[4]	Egerton JR, Ostlind DA, Blair LS, Eary CH, Suhayda D, Cifelli S, Riek RF, Campbell WC . Avermectins, new family of potent anthelmintic agents: efficacy of the B1a component. Antimicrob Agents Chemoth, 1979,15(3):372-378.
[5]	Chabala JC, Mrozik H, Tolman RL, Eskola P, Lusi A, Peterson LH, Woods MF, Fisher MH, Campbell WC, Egerton JR, Ostlind DA . Ivermectin, a new broad-spectrum antiparasitic agent. J Med Chem, 1980,23(10):1134-1136.
[6]	Campbell WC, Fisher MH, Stapley EO, Albers-Sch?nberg G, Jacob TA . Ivermectin: A potent new antiparasitic agent. Science, 1983,221(4613):823-828.
[7]	Kass IS, Wang CC, Walrond JP, Stretton AO . Avermectin B1a, a paralysing anthelmintic that affects interneurons and inhibiting motoneurons in Ascaris. Proc Natl Acad Sci USA, 1980,77(10):6211-6215.
[8]	McKellar QA, Benchaoui HA . Avermectins and milbemycins. J Vet Pharmacol Ther, 1996,19(5):331-351.
[9]	Wolstenholme AJ, Rogers AT . Glutamate-gated chloride channels and the mode of action of the avermectin/ milbemycin anthelmintics. Parasitology, 2005,131(Supp1.):S85-S95.
[10]	Lim LE, Vilcheze C, Ng C, Jacobs WR Jr, Ramon-Garcia S, Thompson CJ . Anthelmintic avermectins kill Mycobacterium tuberculosis, including multidrug-resistant clinical strains. Antimicrob Agents Chemoth, 2013,57(2):1040-1046.
[11]	Guo H, Ren B, Dai H, Dai S, Zhang Y, Liu Y, Cao B, Zhang L . Reversal of meticillin resistance in Staphylococcus aureus by the anthelmintic avermectin. Int J Antimicrob Agents, 2014,44(3):274-276.
[12]	Omura S, Crump A . Ivermectin: Panacea for resource-poor communities. Trends Parasitol, 2014,30(9):445-455.
[13]	Juarez M, Schcolnik-Cabrera A, Due?as-Gonzalez A . The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug. Am J Cancer Res, 2018,8(2):317-331.
[14]	Ikeda H, ōmura S . Avermectin biosynthesis. Chem Rev, 1997,97(7):2591-2610.
[15]	Ikeda H, Nonomiya T, Usami M, Ohta T, Omura S . Organization of the biosynthetic gene cluster for the polyketide anthelmintic macrolide avermectin in Streptomyces avermitilis. Proc Natl Acad Sci USA, 1999,96(17):9509-9514.
[16]	Chen J, Liu M, Liu X, Miao J, Fu C, Gao H, Müller R, Zhang Q, Zhang L . Interrogation of Streptomyces avermitilis for efficient production of avermectins. Synth Syst Biotechnol, 2016,1(1):7-16.
[17]	Ikeda H, Pang CH, Endo H, Ohta T, Tanaka H, Omura S . Construction of a single-component producer from the wild-type avermectin producer Streptomyces avermitilis. J Antibiot, 1995,48(6):532-534.
[18]	Stutzman-Engwall K, Conlon S, Fedechko R, McArthur H, Pekrun K, Chen Y, Jenne S, La C, Trinh N, Kim S, Zhang YX, Fox R, Gustafsson C, Krebber A . Semi-synthetic DNA shuffling of aveC leads to improved industrial scale production of doramectin by Streptomyces avermitilis. Metab Eng, 2005,7(1):27-37.
[19]	Sun P, Zhao Q, Yu F, Zhang H, Wu Z, Wang Y, Wang Y, Zhang Q, Liu W . Spiroketal formation and modification in avermectin biosynthesis involves a dual activity of AveC. J Am Chem Soc, 2013,135(4):1540-1548.
[20]	ōmura S, Ikeda H, Ishikawa J, Hanamoto A, Takahashi C, Shinose M, Takahashi Y, Horikawa H, Nakazawa H, Osonoe T, Kikuchi H, Shiba T, Sakaki Y, Hattori M . Genome sequence of an industrial microorganism Streptomyces avermitilis: deducing the ability of producing secondary metabolites. Proc Natl Acad Sci USA, 2001,98(21):12215-12220.
[21]	Ikeda H, Ishikawa J, Hanamoto A, Shinose M, Kikuchi H, Shiba T, Sakaki Y, Hattori M, ōmura S . Complete genome sequence and comparative analysis of the industrial microorganism Streptomyces avermitilis. Nat Biotechnol, 2003,21(5):526-531.
[22]	Guo J, Zhao J, Li L, Chen Z, Wen Y, Li J . The pathway- specific regulator AveR from Streptomyces avermitilis positively regulates avermectin production while it negatively affects oligomycin biosynthesis. Mol Genet Genomics, 2010,283(2):123-133.
[23]	Kitani S, Ikeda H, Sakamoto T, Noguchi S, Nihira T . Characterization of a regulatory gene, aveR, for the biosynthesis of avermectin in Streptomyces avermitilis. Appl Microbiol Biotechnol, 2009,82(6):1089-1096.
[24]	Zhuo Y, Zhang W, Chen D, Gao H, Tao J, Liu M, Gou Z, Zhou X, Ye BC, Zhang Q, Zhang S, Zhang LX . Reverse biological engineering of hrdB to enhance the production of avermectins in an industrial strain of Streptomyces avermitilis. Proc Natl Acad Sci USA, 2010,107(25):11250-11254.
[25]	Yang R, Liu X, Wen Y, Song Y, Chen Z, Li J . The PhoP transcription factor negatively regulates avermectin biosynthesis in Streptomyces avermitilis. Appl Microbiol Biotechnol, 2015,99(24):10547-10557.
[26]	Liu X, Cheng Y, Lyu M, Wen Y, Song Y, Chen Z, Li J . Redox-sensing regulator Rex regulates aerobic metabolism, morphological differentiation, and avermectin production in Streptomyces avermitilis. Sci Rep, 2017,7:44567.
[27]	Zhu JY, Chen Z, Li JL, Wen Y . AvaR1, a butenolide-type autoregulator receptor in Streptomyces avermitilis, directly represses avenolide and avermectin biosynthesis and multiple physiological responses. Front Microbiol, , 2017,8:2577.
[28]	Zhu J, Sun D, Liu W, Chen Z, Li J, Wen Y . AvaR2, a pseudo γ-butyrolactone receptor homologue from Streptomyces avermitilis, is a pleiotropic repressor of avermectin and avenolide biosynthesis and cell growth. Mol Microbiol, 2016,102(4):562-578.
[29]	He JM, Zhu H, Zheng GS, Liu PP, Wang J, Zhao GP, Zhu GQ, Jiang WH, Lu YH . Direct involvement of the master nitrogen metabolism regulator GlnR in antibiotic biosynthesis in Streptomyces. J Biol Chem, 2016,291(51):26443-26454.
[30]	Sun D, Zhu J, Chen Z, Li J, Wen Y . SAV742, a novel AraC-family regulator from Streptomyces avermitilis, controls avermectin biosynthesis, cell growth and development. Sci Rep, 2016,6:36915.
[31]	Chen L, Lu Y Chen J, Zhang W, Shu D, Qin Z, Yang S, Jiang W . Characterization of a negative regulator AveI for avermectin biosynthesis in Streptomyces avermitilis NRRL8165. Appl Microbiol Biotechnol, 2008,80(2):277-286.
[32]	Chen L, Chen J, Jiang Y, Zhang W, Jiang W, Lu Y . Transcriptomics analyses reveal global roles of the regulator AveI in Streptomyces avermitilis. FEMS Microbiol Lett, 2009,298(2):199-207.
[33]	Liu Y, Yan T, Jiang L, Wen Y, Song Y, Chen Z, Li J . Characterization of SAV7471, a TetR-family transcriptional regulator involved in the regulation of coenzyme A metabolism in Streptomyces avermitilis. J Bacteriol, 2013,195(19):4365-4372.
[34]	He F, Liu W, Sun D, Luo S, Chen Z, Wen Y, Li J . Engineering of the TetR family transcriptional regulator SAV151 and its target genes increases avermectin production in Streptomyces avermitilis. Appl Microbiol Biotechnol, 2014,98(1):399-409.
[35]	Guo J, Zhang X, Luo S, He F, Chen Z, Wen Y, Li J . A novel TetR family transcriptional regulator, SAV576, negatively controls avermectin biosynthesis in Streptomyces avermitilis. PLoS One, 2013,8(8):e71330.
[36]	Guo J, Zhang X, Chen Z, Wen Y, Li J . Two adjacent and similar TetR family transcriptional regulator genes, SAV577 and SAV576, co-regulate avermectin production in Streptomyces avermitilis. PLoS One, 2014,9(6):e99224.
[37]	Liu W, Zhang Q, Guo J, Chen Z, Li J, Wen Y . Increasing avermectin production in Streptomyces avermitilis by manipulating the expression of a novel TetR-family regulator and its target gene product. Appl Environ Microbiol, 2015,81(15):5157-5173.
[38]	Miyamoto KT, Kitani S, Komatsu M, Ikeda H, Nihira T . The autoregulator receptor homologue AvaR3 plays a regulatory role in antibiotic production, mycelial aggregation and colony development of Streptomyces avermitilis. Microbiology, 2011,157(Pt 8):2266-2275.
[39]	Guo J, Zhang X, Lu XR, Liu WS, Chen Z, Li JL, Deng LH, Wen Y . SAV4189, a MarR-family regulator in Streptomyces avermitilis, activates avermectin biosynthesis. Front Microbiol, 2018,9:1358.
[40]	Jiang L, Liu Y, Wang P, Wen Y, Song Y, Chen Z, Li J . Inactivation of the extracytoplasmic function sigma factor Sig6 stimulates avermectin production in Streptomyces avermitilis. Biotechnol Lett, 2011,33(10):1955-1961.
[41]	Luo S, Sun D, Zhu J, Chen Z, Wen Y, Li J . An extracytoplasmic function sigma factor, σ 25, differentially regulates avermectin and oligomycin biosynthesis in Streptomyces avermitilis. Appl Microbiol Biotechnol, 2014,98(16):7097-7112.
[42]	Sun D, Wang Q, Chen Z, Li JL, Wen Y . An alternative σ factor, σ 8, controls avermectin production and multiple stress responses in Streptomyces avermitilis. Front Microbiol, 2017,8:736.
[43]	Kitani S, Miyamoto KT, Takamatsu S, Herawati E, Iguchi H, Nishitomi K, Uchida M, Nagamitsu T, Omura S, Ikeda H, Nihira T . Avenolide, a Streptomyces hormone controlling antibiotic production in Streptomyces avermitilis. Proc Natl Acad Sci USA, 2011,108(39):16410-16415.
[44]	Chen J, Zhang S, Chu J, Zhuang Y, Luo J, Bai H . Ethanol evolution rate: a new parameter to determine the feeding rate for the production of avermectins by Streptomyces avermitilis. Biotechnol Lett, 2004,26(2):109-113.
[45]	Wu YB, Chu XH, Wang YH, Chu J, Zhuang YP, Zhang SL . Optimization of avermectin fermentation process based on parameter association analysis. J East China Univ Sci Technol, 2007,33(5):643-646.
[45]	巫延斌, 储消和, 王永红, 储炬, 庄英萍, 张嗣良 . 阿维菌素发酵过程参数相关特性研究及过程优化. 华东理工大学学报(自然科学版), 2007,33(5):643-646.
[46]	Yao XY, Chu XH, Zhuang YP, Liang JG, Wang YH, Chu J, Zhang SL . Effect of inoculation methods on avermectin fermentation by streptomyces avermilitis. J Food Sci Biotech, 2009,28(5):682-687.
[46]	姚小员, 储消和, 庄英萍, 梁剑光, 王永红, 储炬, 张嗣良 . 接种方式对阿维菌素发酵过程的影响. 食品与生物技术学报, 2009,28(5):682-687.
[47]	张嗣良, 王永红, 陈凝, 夏建业, 庄英萍, 储炬, 巫延斌, 杭海峰, 黄明志 . 阿维菌素发酵过程优化与放大的方法与装置. 中国: CN101671712, 2010.
[48]	Gao H, Liu M, Liu J, Dai H, Zhou X, Liu X, Zhuo Y, Zhang W, Zhang L . Medium optimization for the production of avermectin B1a by Streptomyces avermitilis 14-12A using response surface methodology. Bioresour Technol, 2009,100(17):4012-4016.
[49]	Gao H, Liu M, Zhou X, Liu J, Zhuo Y, Gou Z, Xu B, Zhang W, Liu X, Luo A, Zheng C, Chen X, Zhang L . Identification of avermectin-high-producing strains by high-throughput screening methods. Appl Microbiol Biotechnol, 2010,85(4):1219-1225.
[50]	Gao H, Liu M, Zhuo Y, Zhou XL, Liu JT, Chen DF, Zhang WQ, Gou ZX, Shang P, Zhang LX . Assessing the potential of an induced-mutation strategy for avermectin overproducers. Appl Environ Microbiol, 2010,76(13):4583-4586.
[51]	Liu M, Gao H, Shang P, Zhou X, Ashforth E, Zhuo Y, Chen D, Ren B, Liu Z, Zhang L . Magnetic field is the dominant factor to induce the response of Streptomyces avermitilis in altered gravity simulated by diamagnetic levitation. PLoS One, 2011,6(10):e24697.
[52]	Li M, Chen Z, Zhang X, Song Y, Wen Y, Li J . Enhancement of avermectin and ivermectin production by overexpression of the maltose ATP-binding cassette transporter in Streptomyces avermiilis. Bioresour Technol, 2010,101(23):9228-9235.
[53]	Li L, Guo J, Wen Y, Chen Z, Song Y, Li J . Overexpression of ribosome recycling factor causes increased production of avermectin in Streptomyces avermitilis strains. J Ind Microbiol Biotechnol, 2010,37(7):673-679.
[54]	Qiu J, Zhuo Y, Zhu D, Zhou X, Zhang L, Bai L, Deng Z . Overexpression of the ABC transporter AvtAB increases avermectin production in Streptomyces avermitilis. Appl Microbiol Biotechnol, 2011,92(2):337-345.
[55]	Zhao X, Wang Q, Guo W, Cai Y, Wang C, Wang S, Xiang S, Song Y . Overexpression of metK shows different effects on avermectin production in various Streptomyces avermitilis strains. World J Microbiol Biotechnol, 2013,29(10):1869-1875.
[56]	Tian P, Cao P, Hu D, Wang D, Zhang J, Wang L, Zhu Y, Gao Q . Comparative metabolomics reveals the mechanism of avermectin production enhancement by S-adenosylmethionine. J Ind Microbiol Biotechnol, 2017,44(4-5):595-604.
[57]	Gaisser S, Kellenberger L, Kaja AL, Weston AJ, Lill RE, Wirtz G, Kendrew SG, Low L, Sheridan RM, Wilkinson B, Galloway IS, Stutzman-Engwall K, McArthur HA, Staunton J, Leadlay PF . Direct production of ivermectin- like drugs after domain exchange in the avermectin polyketide synthase of Streptomyces avermitilis ATCC31272. Org Biomol Chem, 2003,1(16):2840-2847.
[58]	Zhang XL, Chen Z, Zhao JL, Song Y, Wen Y, Li JL . Deletion analysis of oligomycin PKS genes ( olmA) in Streptomyces avermitilis. Chin Sci Bull, 2004,49(4):350-354.
[59]	Zhang X, Chen Z, Li M, Wen Y, Song Y, Li J . Construction of ivermectin producer by domain swaps of avermectin polyketide synthase in Streptomyces avermitilis. Appl Microbiol Biotechnol, 2006,72(5):986-994.
[60]	Li M, Chen Z, Lin X, Zhang X, Song Y, Wen Y, Li J . Engineering of avermectin biosynthetic genes to improve production of ivermectin in Streptomyces avermitilis. Bioorg Med Chem Lett, 2008,18(20):5359-5363.
[61]	Zhang J, Yan YJ, An J, Huang SX, Wang XJ, Xiang WS . Designed biosynthesis of 25-methyl and 25-ethyl ivermectin with enhanced insecticidal activity by domain swap of avermectin polyketide synthase. Microb Cell Fact, 2015,14:152.
[62]	Cropp TA, Wilson DJ, Reynolds KA . Identification of a cyclohexylcarbonyl CoA biosynthetic gene cluster and application in the production of doramectin. Nat Biotechnol, 2000,18(9):980-983.
[63]	Wang JB, Pan HX, Tang GL . Production of doramectin by rational engineering of the avermectin biosynthetic pathway. Bioorg Med Chem Lett, 2011,21(11):3320-3323.
[64]	Sun P, Zhao Q, Wu Z, Zhang W, Liu W . 1,19-seco- avermectin analogues from a ΔaveCDE mutant Streptomyces avermectinius strain. J Nat Prod, 2015,78(2):301-305.
[65]	Wang F, Wang Y, Ji J, Zhou Z, Yu J, Zhu H, Su Z, Zhang L, Zheng J . Structural and functional analysis of the loading acyltransferase from avermectin modular polyketide synthase. ACS Chem Biol, 2015,10(4):1017-1025.
[66]	Zhuo Y, Zhang T, Wang Q, Cruz-Morales P, Zhang B, Liu M, Barona-Gómez F, Zhang L . Synthetic biology of avermectin for production improvement and structure diversification. Biotechnol J, 2014,9(3):316-325.
[67]	Ikeda H, Kazuo SY, Omura S . Genome mining of the Streptomyces avermitilis genome and development of genome-minimized hosts for heterologous expression of biosynthetic gene clusters. J Ind Microbiol Biotechnol, 2014,41(2):233-50.
[68]	Komatsu M, Uchiyama T, Omura S, Canec DE, Ikeda H . Genome-minimized Streptomyces host for the heterologous expression of secondary metabolism. Proc Natl Acad Sci USA, 2010,107(6):2646-2651.
[69]	Komatsu M, Komatsu K, Koiwai H, Yamada Y, Kozone I, Izumikawa M, Hashimoto J, Takagi M, Omura S, Shin-Ya K, Cane DE, Ikeda H . Engineered Streptomyces avermitilis host for heterologous expression of biosynthetic gene cluster for secondary metabolites. ACS Synth Biol, 2013,2(7):384-396.
[70]	Yamada Y, Arima S, Nagamitsu T, Johmoto K, Uekusa H, Eguchi T , Shin-ya K, Cane DE, Ikeda H. Novel terpenes generated by heterologous expression of bacterial terpene synthase genes in an engineered Streptomyces host. J Antibiot, 2015,68(6):385-394.
[71]	Bai C, Zhang Y, Zhao X, Hu Y, Xiang S, Miao J, Lou C, Zhang L . Exploiting a precise design of universal synthetic modular regulatory elements to unlock the microbial natural products in Streptomyces. Proc Natl Acad Sci USA, 2015,112(39):12181-12186.
[72]	Gao Q, Tan GY, Xia X, Zhang L . Learn from microbial intelligence for avermectins overproduction. Curr Opin Biotechnol, 2017,48:251-257.
[73]	Chen J, Miao J, Liu M, Liu X, Bao L, Jiang Y, Wang D, Zhang Q, Zhang L . Different fates of avermectin and artemisinin in China. Sci China Life Sci, 2016,59(6):634-636.

编辑推荐

Metrics

www.chinagene.cn
备案号：京ICP备09063187号-4
总访问:,今日访问:,当前在线:

阿维菌素的中国“智”造

Avermectins, intelligently made in China

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 0

编辑推荐

Metrics